Petrovax Pharm is a Russian company of company of novel biopharmaceutical practices, actively investing in scientific research and development.

The product portfolio includes original pharmaceutical products and vaccines, biotech drugs, and branded generics. The in-house R&D center supports a full cycle of drug development.

The company’s complex manufacturing for APIs and finished dosage forms is located in the Moscow region and operates in full compliance with the EAEU and EU GMP standards.

Petrovax’s development strategy focuses on providing patients with in-demand vaccines and drugs for the prevention and treatment of infectious, oncological, and orphan diseases.

Petrovax is implementing international projects with leading pharmaceutical companies: Pfizer, Abbott, ISU ABXIS, Adimmune, Hengrui. The company is one of the largest Russian exporters of original medicines and vaccines to the countries of the EAEU and the EU.

Our mission: Expanding access to cutting-edge therapies.